Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$69.92
pos +2.64
+3.92%
Today's Range: 69.28 - 70.15 | ESRX Avg Daily Volume: 5,092,500
Last Update: 07/30/14 - 11:16 AM EDT
Volume: 4,966,960
YTD Performance: -4.21%
Open: $69.76
Previous Close: $67.28
52 Week Range: $59.20 - $79.37
Oustanding Shares: 773,580,000
Market Cap: 50,978,922,000
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 13 13
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.50 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 28.90
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
28.90 29.80 28.94
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.25% 0.52% 24.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.28 $1.39 $4.87 $5.50
Number of Analysts 13 13 16 16
High Estimate $1.33 $1.44 $4.90 $5.62
Low Estimate $1.22 $1.33 $4.80 $5.36
Prior Year $1.08 $1.12 $4.33 $4.87
Growth Rate (Year over Year) 18.09% 24.11% 12.40% 13.07%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
This stock is a steady climber, and it's at a glaring entry point.

Who's Trimmed and Who's Out Real Money Pro($)

Today I reduced my exposure in the following stocks:
If you have confidence in Walgreen's management it seems the better choice.

Stocks That Flash a Warning Real Money Pro($)

Express Scripts, Loews, Facebook, Baidu, Clorox and Intel are red in an aggressively green market.
Bullish
Nov 16, 2012 | 8:01 AM EST
ESRX was upgraded to Buy from Neutral, Citigroup said. $62 price target. Compelling valuation and sell-off overdone. 
The slow, prolonged selloff continues, despite good fundamental news.
Even a very conservative scenario would provide for a very nice total return by next year.

Self-Medicating Real Money Pro($)

I bought more Express Scripts.
Bearish
Nov 07, 2012 | 9:04 AM EST
Shares of ESRX now seen reaching $60, Oppenheimer said. Estimates also lowered on utilization headwinds. Outperform rating.
Bearish
Nov 07, 2012 | 8:25 AM EST
Shares of ESRX now seen reaching $62, Citigroup said. Estimates also lowered after company pulls forward 2013 EPS. Neutral rating. ...

Columnist Conversations

I had shorted a number of CH Robinson (CHRW) puts with 2015 and 2016 expiration dates back when the shares wer...
as of right now, 11am, with the Dow 30 at 16,855 means that the Dow 30 is up 1.60% for 2014.
Shares of BWLD are taking a beating this morning. The stock is off over 12% after opening the session wi...
Garmin Ltd (GRMN) With the July 3 high @ 62.05 GRMN opened @ 61.60 today and failed to clear the recent 62....

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.